Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Immuno-oncology therapy developer Lava Therapeutics has filed for a $100m IPO, having been set up in 2016 to exploit Amsterdam University Medical Centers research.

Century Therapeutics sells Bayer on $160m…

Versant Ventures, which incubated the cell-based immunotherapy developer based on Harvard and Stanford research, has backed a $160m round.


GCVI Summit 2021
29th September 2021
Go Further Index Event
28th April 2021
Daily deal net: March 4, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Veir conducts $10m series A operation
The Engine and Congruent Ventures have both participated in a series A round for the developer of high-voltage superconducting transmission lines.
Caribou clinches $115m series C
UC Berkeley-founded genome editing technology developer Caribou Biosciences has completed its first funding round in five years.
Exscientia expands series C to $100m
BlackRock has joined the University of Dundee spinout’s series C round, following a $60m first close in May last year.
Reflexion reconsiders series D round
Exploiting UChicago research, Reflexion is eyeing an expansion in Asia after receiving $40m in additional series D funding to bring the round to $150m.
DocuVision pictures acquisition deal
OneTrust has acquired DocuVision, providing exits to investors including Berkeley SkyDeck Fund and Oxford Seed Fund.
test reg